Skip to main content

Table 1 Participant characteristics (n = 11)

From: Daily variations of gut microbial translocation markers in ART-treated HIV-infected people

IDAgeBody mass index(kg/m2)CD4 count (cells/µL)CD8 counts (cells/µL)ART duration (years)Viral loadCurrent ART medication
16027.8602132110UndetectableEmtricitabine, TDF, raltegravir
25227.149161321UndetectableEmtricitabine, TDF, raltegravir
35728.460685512UndetectableEmtricitabine, TDF, raltegravir
45732.984690122UndetectableEmtricitabine, TDF, darunavir, cobicistat
55724.941092431UndetectableEmtricitabine, TDF, efavirenz
66327.766755315UndetectableAbacavir, dolutegravir, lamivudine
75034.937949819UndetectableEmtricitabine, TDF, raltegravir
85826.131133121UndetectableEmtricitabine, TDF, elvitegravir, cobicistat
95724.680059713UndetectableAbacavir, dolutegravir, lamivudine
105832.167549413UndetectableAbacavir, dolutegravir, lamivudine
115423.91082142517UndetectableLamivudine, abacavir, raltegravir
  1. TDF, tenofovir disoproxil fumarate